Phillips Barclay A - Insider Stock Trading - OpenInsider

CIK: 1265801 - Address: 1200 Avenue of the Americas, Suite 200, New York, NY 10036

15 results

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	13	4	6	10	2	35	64	20
P	%wins				92	83	75	67	73	70	77

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
8/1/17 17:26	7/31/17	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	2	0.8900	0	2	6	39	D
5/11/17 10:45	5/11/17	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	21	0.8380	4	25	215	37	D	-90	-82	-44	-37	-35	1	1	12	12
2/2/17 16:10	1/31/17	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	2	1.12	8	2	16	12	D	-83	-72	-82	-14	-7	-4	-4	-2	4	2	15	-38
8/2/16 18:17	7/31/16	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	2	4.29	31	0	4	10	D	69	-39	46	38	8	-5	-1	-1	6	4	-3	-78	-80
2/1/16 17:34	1/31/16	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	2	4.38	33	0	4	10	D	-10	-34	-57	-30	-41	-27	-17	-9	-7	-4	-7	4	44	-73
8/4/15 16:46	7/31/15	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	2	2.28	33	1	2	38	D	352	184	57	51	22	0	1	2	2	-5	-10	-41	-58	-38
2/3/15 17:05	1/31/15	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	19	2.28	33	8	29	37	D	331	42	81	37	30	20	5	1	3	7	18	7	60	-36
10/6/14 10:17	10/3/14	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	21	4.11	12	5	21	29	D	72	27	0	-13	-9	-9	-5	-1	2	7	34	43	95	73
8/4/14 15:12	7/31/14	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	20	2.28	14	9	59	24	D	95	59	-22	-1	-15	-5	-6	-5	3	2	14	32	81	184
3/25/14 14:09	3/25/14	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P.a	21	4.25	33	5	51	15	D	215	91	32	-12	-29	-35	-24	-20	8	10	1	18	4	124
3/25/14 12:07	3/25/14	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	21	4.25	33	5	51	15	D	215	91	32	-12	-29	-35	-24	-20	8	10	1	18	4	124
2/4/14 09:22	1/31/14	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P	23	2.29	32	10	New	10	D	251	194	99	71	13	-4	-17	-7	2	10	20	-18	-17	41
7/5/13 13:03	6/12/13	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	O	SVP,CFO	P.a	0	0.00	3	0		0	D	16	51	19	3	15	21	16	15	11	9	13	38	122	113
7/3/13 10:40	6/12/13	NVAX	Novavax Inc	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	MD	D		P	95	1.90	3	50	33	200	D	11	53	19	-6	15	18	12	14	4	16	19	41	128	123
11/6/03 18:01	11/4/03	CNVX	Cancervax Corp	DE	Health	BioPrd	Biological Products, (No Diag	Phillips Barclay A	CA	D		P	6	12.00	0	1	8	7	M

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

Return to top

Contact